Evotec AG is paying €10.25 million in cash upfront to acquire the US compound management business of Galápagos NV in a move that will substantially increase its ability to help third parties develop and manage their compound libraries. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
